Related Experiment Video
Updated: Jun 15, 2026
Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces
Published on: September 26, 2014
The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells
Jun Cheng1, Lin Zhou, Qin-Fen Xie
1Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Hangzhou, PR China.
Abstract:
MicroRNAs are small non-coding RNA molecules that play essential roles in biological processes ranging from cell cycle to cell migration and invasion. Accumulating evidence suggests that miR-34a, as a key mediator of p53 tumor suppression, is aberrantly expressed in human cancers. In the present study, we aimed to explore the precise biological role of miR-34a and the global protein changes in HCC cell line HepG2 cells transiently transfected with miR-34a. Transfection of miR-34a into HepG2 cells caused suppression of cell proliferation, inhibition of cell migration and invasion. It also induced an accumulation of HepG2 cells in G1 phase. Among 116 protein spots with differential expression separated by 2-DE method, 34 proteins were successfully identified by MALDI-TOF/TOF analysis. Of these, 15 downregulated proteins may be downstream targets of miR-34a. Bioinformatics analysis produced a protein-protein interaction network, which revealed that the p53 signaling pathway and cell cycle pathway were two major hubs containing most of the proteins regulated by miR-34a. Cytoskeletal proteins such as LMNA, GFAP, MACF1, ALDH2, and LOC100129335 are potential targets of miR-34a. In conclusion, abrogation of miR-34a function could cause downstream molecules to switch on or off, leading to HCC development.
Insights
MicroRNA 34a (miR-34a) suppresses hepatocellular carcinoma (HCC) cell proliferation and invasion by regulating key protein pathways. Loss of miR-34a function may drive HCC development by altering downstream molecular targets.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are crucial regulators of cellular processes.
- miR-34a is a tumor suppressor linked to the p53 pathway and is dysregulated in cancers.
- Hepatocellular carcinoma (HCC) development involves complex molecular alterations.
Purpose of the Study:
- To investigate the biological role of miR-34a in HCC.
- To identify global protein changes in HepG2 cells following miR-34a transfection.
- To elucidate the molecular pathways affected by miR-34a in HCC.
Main Methods:
- HepG2 cells were transiently transfected with miR-34a.
- Cell proliferation, migration, and invasion assays were performed.
- Differential protein expression was analyzed using 2D-gel electrophoresis (2-DE) and MALDI-TOF/TOF mass spectrometry.
- Bioinformatics tools were used for pathway and network analysis.
Main Results:
- miR-34a transfection suppressed HepG2 cell proliferation, migration, and invasion.
- Cells exhibited G1 phase accumulation post-transfection.
- 34 differentially expressed proteins were identified, with 15 showing downregulation and potential miR-34a targeting.
- p53 and cell cycle pathways emerged as major hubs regulated by miR-34a.
- Potential miR-34a targets include cytoskeletal proteins like LMNA, GFAP, MACF1, ALDH2, and LOC100129335.
Conclusions:
- miR-34a plays a significant role in suppressing HCC progression.
- Dysregulation of miR-34a leads to altered expression of downstream proteins, potentially driving HCC.
- Targeting miR-34a or its downstream effectors could offer therapeutic strategies for HCC.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019